Who We Are

  INDOX founders

Professor David Kerr, Professor of Cancer Medicine, University of Oxford

David Kerr has made sustained and internationally recognised contribution to cancer care and research in the field of drug development over the past 3 decades. He has published over 400 papers in high profile journals (H-Index= 57, Citations=12,000), authored over twenty books including the Oxford Textbook of Oncology, and has been awarded 4 prestigious, international research prizes, including the NHS’s first Nye Bevan award for Innovation.  He is listed as the doctor’s doctor and sees patients from all around the world His scientific standing has been recognised by election as Fellow of Academy of Medical Sciences in 2000 , President of the European society of Medical Oncology ( 2009-2011) and Founding  Fellow of the  European Academy of  Cancer Sciences (2010).

He Chaired the Cancer Services Collaborative (1999-2003), working with Don Berwick to deliver the world’s largest redesign programme in order to improve delivery of the NHS’ cancer service (he was awarded CBE 2002).  Since then, he has completed the “Kerr Report” (2006), a 20 year plan to reform Scotland’s NHS – a root and branch review of every aspect of the NHS. He has brought world-wide attention to the looming epidemic of cancer which will claim the lives of more than a million Africans every year.  He organised the first ever African Cancer Reform convention in London (2007).  This was attended by 27 African Health ministries, led to the London Declaration (www.afrox.org) calling for immediate action to develop cancer control plans for these nations.  AfrOx has already received international support (WHO, IAEA) and is seen as a beacon model for establishing cancer control in Africa and is helping to coordinate the international oncology community’s engagement in this field. He has supported two British Prime Ministers (Tony Blair and David Cameron) in a health advisory role and has served on Qatar’s Supreme Health Council.

Professor Vinod Raina, Head of Medical Oncology, Institute Rotary Cancer Hospital and All India Institute of Medical Sciences (AIMS), New Delhi

At the time of the foundation of INDOX, Professor Vinod Raina was the Head of Medical Oncology at the Institute Rotary Cancer Hospital and All India Institute of Medical Sciences (AIMS), New Delhi. In 2013 he moved to Fortis Memorial Research Centre, where he is the Head of Department and Director - Medical Oncology and Haematology.  He was the Head of the Delhi Cancer Registry from 2004 - 2013, was appointed an Honorary Senior Research Fellow of Oxford University for five years from June 2005 and was a WHO Visiting Fellow in USA and Canada 1997.  He has led approximately 40 international, institutional, drug company and local research projects.  He has authored more than 100 publications in national and international journals.  His main interests are breast cancer, gastrointestinal, genitourinary, Lymphomas and Leukemias, Myeloma, transplants and cancer registries. He was Senior Consultant and Head of Oncology, Royal Hospital, Muscat, Oman (2001 – 2004); Senior Research Fellow, Medical Oncology and Medicine, Royal Infirmary, Glasgow (1986-1989) and Lecturer and Assistant Professor of Medicine, Al Fateh University, Tripoli, Libya (1980-1986).  His awards include: Shiromani award for carrying out simplified and cost-effective stem cell transplants in India, 1995, N.B. Mishra oration on Non Hodgkin’s Lymphoma in AIMS, 1997, and an oration by Indian Society of Medical and Paediatric Oncology in Pune, 2005.  Professor Raina was the co-founder of the INDOX Cancer Research Network.  

Dr Raghib Ali, INDOX Director, University of Oxford

Dr Raghib Ali is the Director of the INDOX Cancer Research Network and Clinical Epidemiologist at the Cancer Epidemiology Unit at the University of Oxford. He is also an Honorary Consultant in Acute Medicine at the John Radcliffe Hospital in Oxford. His main research interests are the aetiology, prevention & treatment of cancer in South Asian and Middle Eastern populations. He is the Principle Investigator for a number of studies in India and for the British Asian Health study. He graduated from Cambridge University in 1999 with a distinction in Medicine and was awarded the John Addenbrookes prize for Medicine. He completed his clinical training in General (Internal) Medicine and Clinical Pharmacology from the Oxford Deanery in 2009.

INDOX Coordinating Centre (ICC), Oxford

Professor Dame Valerie Beral, Head of Cancer Epidemiology Unit, University of Oxford

Professor Dame Valerie Beral, FRS was made a Dame for her services to science in January 2010.  She is Professor of Epidemiology at the University of Oxford and Director of the Cancer Research UK Epidemiology Unit.  Her team is looking at how a woman's lifestyle, including her reproductive and family history, can influence her health and whether she is likely to develop breast cancer.  Professor Beral studied medicine at Sydney University, Australia. After a few years of clinical work in Australia, New Guinea and the UK, she spent almost 20 years at the London School of Hygiene & Tropical Medicine working in the Department of Epidemiology. In 1988 she became the Director of the Cancer Epidemiology Unit in Oxford. Major focuses of her research include the role of reproductive, hormonal and infectious agents in cancer. She is Principal Investigator for the Million Women Study and leads the international collaborative studies of breast, ovarian and endometrial cancer.

Dr Isobel Barnes, INDOX Statistician, University of Oxford

Dr Isobel Barnes is a medical statistician and has been working for the INDOX Cancer Research Network since June 2007.  She is based at Oxford University and performs data analyses for the epidemiological studies conducted by INDOX.

Dr Alexander Finlayson, University of Oxford

Alexander Finlayson BMedSci (hons), MBBS (hons) is a medic.  He worked with Dr Bryan McIver on the molecular biology of thyroid cancer in The Department of Endocrinology at The Mayo Clinic in Rochester Minnesota.  He then received a Kennedy Scholarship to study Cellular Metastasis, Systems Biology and Personalised Medicine as a Visiting Fellow at Harvard University with Professor Phil Leder.  Following this Alexander worked on the Academic Foundation Programme at King's College Hospital, London.  He conducted clinical studies on hypoglycaemia and travelled to Somaliland as part of a health systems strengthening project called The King's THET Somaliland Partnership.  He started and is now the CEO of an organisation called Medicine Africa which supports the education of healthcare professionals in hard to reach, fragile states.  He is the Head of Research at the King's Centre for Global Health at King's College London.  Alexander then worked as an NIHR Academic Clinical Fellow in Cancer Medicine at Oxford University.  He is a Tutor for Graduate Entry Medical Students at Green Templeton College, Oxford and is the Chairman of the Trainees Committee of the Oxford Deanery.  In August 2013, he returned to full time academic clinical training as an Academic Clinical Fellow in General Practice.

Ms Mary Foulkes, INDOX Project Co-ordinator, University of Oxford

Mary Foulkes is a project co-ordinator at INDOX and has been working for the network since 2009.  She has responsibility for the INDOX Training and Fellowship Scheme, as well as co-ordinating meetings, communications and general administration.

Dr Toral Gathani, Clinical Epidemiologist, University of Oxford

Dr Toral Gathani is a Clinical Epidemiologist at the Cancer Epidemiology Unit, University of Oxford, and also a Consultant Oncoplastic and Reconstructive Breast Surgeon.  Her clinical practice is at the Oxford University Hospitals NHS Trust.

Her main research interests lie in breast cancer epidemiology and she received her epidemiology training at the Cancer Epidemiology Unit in Oxford where she completed the work for her doctoral thesis under the supervision of Professor Valerie Beral.  She is the principal investigator for INDOX's epidemiological studies relating to breast cancer, and has spent a considerable amount of time working in India both in a research and clinical capacity.

Mr Sanjay Gupta, INDOX Coordinator India

Mr Sanjay Gupta has conducted and supervised over 80 clinical trials (including global registration trials, exploratory Phase-II trials, Phase-I trials and investigator initiated trials) across a wide range of therapeutic areas including Oncology, Endocrinology, Psychiatry, Critical Care, Infectious Diseases, Andrology, and Ophthalmology. He has presented his research work in various international journals and conferences including American Society of Clinical Oncology (ASCO), Seminars in Oncology, British Journal of Cancer (BJC), Gastric & Breast Cancer (GBC) and British Journal of Radiology (BJR) and has also authored 5 books. He is the Indian Coordinator for the INDOX Cancer Trial Network which he joined in 2006. As the network coordinator he has been involved in executing the quality initiatives, other activities of the network, and is the first point of contact for the Indian INDOX sites. 

Dr Shameq Sayeed, University of Oxford

Dr Shameq Sayeed is a (Honorary) Clinical Research Fellow working with INDOX.  He qualified from Oxford University Medical School (BA, BM BCH) in 2009, and on completion of his Foundation School training, took up his current research post, alongside which he is pursuing an MSc in Epidemiology (LSHTM). In August 2013, he returned to full time academic clinical training as an Academic Clinical Fellow in General Practice.

The main focus of his work with INDOX is in studying cancer incidence within ethnic groups in the UK and working towards establishing the British Asian Cohort Study.

Principal Investigators

Dr Neeraj Bhala, University of Oxford

Dr Neeraj Bhala is a Medical Research Council fellow in medicine and epidemiology (population health) at the University of Oxford, as well as being a practising clinician in gastroenterology. He is particularly involved in large-scale studies looking at the benefits and risks of common treatments like aspirin, statins and NSAIDs. Other interests include liver disease, cancer and training in medicine. He is also involved in global health studies, particularly in the UK and the Indian subcontinent.

Dr Raghunadharao Digurmarti, Head of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad

Dr Raghunadharao Digumarti is the Head of Department of Medical Oncology at the Nizam’s Institute of Medical Sciences, Hyderabad.  He established the first Medical oncology department and a comprehensive cancer care centre for the state of Andra Pradesh (1989), established a hospital-based registry (1989) and a subsidised cancer pharmacy (1992).  He undertook the first phase 1 in cancer patients for both indigenous and foreign molecules.  He has completed over 100 clinical trials since 1993 in all phases.  He was the first ACRP Certified Clinical Research Physician in India 2004.  He started a DM Medical Oncology Program in 2005, founded the Medical Oncology Forum for the State in 2005, started the Twin Cities Cancer Club 2004, and started the Childhood Cancer Study Group, 2007.  He was recognized by the University of Oxford for developing an early phase cancer clinical trials unit.  He has collaborated with Breast International Group, Osmania University, CDFD, Central University, ICRISAT in pre-clinical cancer research.

Professor Raju Titus Chacko, Head of Medical Oncology, Christian Medical College, Vellore

Dr Raju Titus Chacko is Professor & Head of Medical Oncology and an Associate Director at the Christian Medical College, Vellore.  He has been the co-investigator in more than 30 multicentric international trials and primary investigator in more than 50 multicentric national and international trials.  His main research interests are in early drug development, targeted therapy, molecular biology of malignant tumours and early phase trials.

Dr.T.S.Ganesan, Chairman of Cancer Institute, Cancer Institute (WIA), Chennai

Dr. T.S.Ganesan graduated 'Summa cum Laude' from Jawaharlal Institute of Medical Education and Research, Pondicherry, India.  He completed his training in Medical Oncology at St. Bartholomew's Hospital, London.  His doctorate was on Philadelphia chromosome positive Leukemias awarded by the University of London.  He was subsequently appointed as Consultant Medical Oncologist at The Churchill Hospital, Oxford and established a laboratory as a Clinical Scientist at the Weatherall Institute of Molecular Medicine, Oxford.  He was the first clinician scientist in Medical Oncology and was awarded a 5 year program grant by ICRF that was renewed for 15 years.  He was also a Reader in Medical Oncology at Oxford University.  After 15 years at Oxford he was appointed as Chairman, Cancer Institute and Institute of Molecular Medicine and Professor of Medical Oncology at Amrita Institute of Medical Sciences, Cochin, India towards the end of 2005.  He established the Institute of Molecular Medicine at Amrita Institute of Medical Sciences.  He moved to Cancer Institute, Chennai in June 2012 where he holds the chair in Medical Oncology and is head of Clinical Research. His research interests have been on cancer genetics and signal transduction, in addition to clinical trials.  He has contributed to performing early phase trials by gene therapy, antibodies and vaccines in addition to novel drugs in cancer.  He has been awarded the Clinical Excellence award in the UK during his tenure there.  He has been a member of the Medical Research Council, UKCCR and NICE advisory committees.  In India, he has been a member of the DBT advisory committees.  He has supervised over 25 doctoral students and post-doctoral fellows.  He has over 120 papers to his credit in international journals.  He has published over 300 abstracts at scientific conferences.

Dr.R. Ravi Kannan, Director, Cachar Cancer Hospital and Research Centre, Silchar

Dr R. Ravi Kannan is Director of the Cachar Cancer Hospital and Research Centre, Silchar.  He was formerly Professor and Head of the Department of Surgical Oncology and Head of the Head and Neck Division of the Cancer Institute (WIA), Chennai.

Dr K.C. Lakshmaiah, Head of the Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore

Dr.K.C.Lakshmaiah is currently Professor and Head of the Department of Medical Oncology at Kidwai Memorial Institute of Oncology, Bangalore.  After joining as a lecturer in Dept of Medical Oncology in 1990 he has held various posts before becoming the Head of department.  He has also worked as a consultant in Haemato-oncology in Assir Central Hospital, King Khalid University Abha, Kingdom of Saudi Arabia.  As a Principle Investigator he has undertaken more than 30 Trials and has more than 30 publications in national and international indexed journals.   He has been invited as an expert for protocol amendment in the Phase I trial BAY 365722 at Barcelona, Spain.  He is involved as an expert reviewer for clinical trials submitted to DCGI for approval.  Apart from this he has vast experience in conducting Phase I, II and III clinical trials involving breast cancer, gastric cancer, colon cancer, pancreatic cancer, ovarian cancer, non-small cell lung cancer, multiple myeloma, prostate cancer and other cancers involving bone health. He has also been awarded from the International Association for the Study of Lung Cancer as a member of good standing in promoting the study of lung cancer - IASLC University of Colorado, USA in April 2008.

Dr Dasappa Lokanatha, Associate Director, Division of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore

Dr Dasappa Lokanatha is currently Associate Professor in the Department of Medical Oncology at the Kidwai Memorial Institute of Oncology, Bangalore.  He was previously a Consultant in the Department of Medical Oncology at the Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India (2002 – 2003); and Lecturer (Medical Oncology) at the Kidwai Memorial Institute of Oncology, Bangalore, India (1992 – 2002).  He has experience in running phase I, II and III trials – including Non-Hodgkin’s Lymphoma, advanced metastatic breast cancer, mucositis, Febrile Neutropenia and Non-small cell lung cancer.

Prof Dr. Hemant Malhotra, Head of Medical Oncology, Birla Cancer Center, SMS Medical College Hospital, Jaipur

Prof. Dr. Hemant Malhotra is Professor of Medicine & Head of Division of Medical Oncology at the Birla Cancer Center, SMS Medical College Hospital, Jaipur. He set up the Medical Oncology division at the SMS Hospital in 1991, the first in the state of Rajasthan. Very recently, he has established a Bone Marrow Transplantation Unit at the SMS and his team has successfully done the first-ever autologous bone marrow transplantation in the state of Rajasthan. He is an internationally and nationally recognized medical oncologist and was the India, Pakistan & Bangladesh representative to the European Society for Medical Oncology (ESMO) from 2006 to 2008. He is an advisor/consultant/referee/committee member for oncology to several Government of India bodies and head the ICMR committee for formulation of guidelines for multiple myeloma. He has been an invited consultant to the WHO on guideline development for bio-similar oncology molecules. Prof Dr. Malhotra has to his credit more than 200 international and national publications and presentations and is an office bearer and member of many international and national societies and organizations. He is the present secretary of the Indian Society of Medical & Pediatric Oncology (ISMPO).

Professor Mohandas K. Mallath, Senior Consultant in Digestive Diseases, Tata Memorial Center, Kolkata

Content being updated

Dr Beela Sarah Mathew, Additional Professor, Division of Radiation Oncology, Regional Cancer Centre, Trivandrum

Dr Beela Sarah Mathew is currently Additional Professor of Radiation Oncology at the Regional Cancer Centre, Trivandrum. Her research interests are in developing new approaches for early diagnosis and treatment for breast cancer and treatment of adult brain tumors. She has been involved as co-investigator in 9 and as Principal Investigator in 8 clinical trials with experience in both phase II & III trials.

Dr Chandramohan Krishnan Nair, Associate Professor, Division of Surgical Oncology, Regional Cancer Centre, Trivandrum, Kerala

Dr Chandramohan Krishnan Nair is Associate Professor at the Department of Surgical Oncology, Regional Cancer Centre, Trivandrum, Kerala, India.  His research interests are the genetics, epidemiology, quality of life and health economics of colorectal cancers.  His current research includes: Tumour Primordial Cells in Colorectal Cancer: Implications for Surgical Margins and Minimal Residual Disease, sponsored by Department of Biotechnology, Government of India; Translation and validation of EORTC QLQ CR29 questionnaire; and a study of the clinical and pathologic aspects of truncal and extremity soft tissue sarcomas.  He is also currently collaborating with INDOX on the INDOX Case-control Consortium.

Dr. Rajiv Ranjan Prasad, Head of Medical Oncology, Regional Cancer Centre, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna

Dr. Rajiv Ranjan Prasad is Additional Professor & Head of Department at the Regional Cancer Centre, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna.  He has 18 years of experience in medical oncology and has been principal investigator on over 25 multicentric, multinational trials in phase I to III.  He has participated in several Government of India & WHO-India initiated programmes as nodal officer. He has established for the first time many facilities related to cancer in the state of Bihar e.g. palliative care and high dose rate brachytherapy.  He has several publications and has contributed many Chapters in the Oncology textbooks Published by Churchill Living Stone & Elsevier Press. He has worked as a member of the national task force to formulate the strategy for cancer control in India for the Ministry of Health & Family Welfare, Govt. of India.  He has also worked as a member of the editorial review board for Conquering Cancer in India, an Indian cancer initiative of the American Cancer Society.

Dr Arumugham Rajkumar, Head of Medical Oncology, G. Kuppusamy Naidu Memorial Hospital, Coimbatore

Dr Arumugham Rajkumar is the Head of the Department of Medical Oncology at G. Kuppusamy Naidu Memorial Hospital, Coimbatore.  His research interests include concurrent chemoradiation in head and neck cancers; utility and feasibility of anato-metabolic imaging in brain tumors and the prevalence of Helicobacter pylori in patients with carcinoma stomach. He has experience in phase II and phase III clinical trials.  He has received awards for Best Scientific Paper award at the XIV Annual conference of UP Chapter of Association of Radiation Oncologists of India (AROI), Lucknow,2001 and the J.M. Pinto Memorial Award for the Best Paper, 23rd Annual National Conference of Association of Radiation Oncologists of India (AROI), Chandigarh, 2001.  The G.Kuppuswamy Naidu Memorial Hospital joined INDOX in 2009 and Dr Rajkumar is the Principal Investigator.  They hope to participate in research with the INDOX network in the future.

Dr Paul Sebastian, Director, Regional Cancer Centre, Trivandrum, Kerala

Dr Paul Sebastian is the Director of Regional Cancer Centre, Trivandrum, India (RCC) and is a professor of surgical oncology and head of the Head and Neck Service.  Dr Sebastian was instrumental in developing RCC as a major centre for teaching and training in oncology by starting several courses, including MCh Surgical Oncology and the Head and Neck Fellowship programme. His research interests include prevention of head and neck cancer; etiology of oral cancer in young patients; and development of simple, low cost treatment strategies for head and neck cancers suitable for countries with limited resources. He is the principal investigator of several national and international collaborative research projects in head and neck cancer and has 45 peer-reviewed publications in indexed journals to his name. For his contributions, he was awarded the Best Doctor Award by the Government of Kerala in 2008

Dr Atul Sharma, Additional Professor of Medical Oncology, All India Institute of Medical Sciences, New Delhi

Dr Atul Sharma is the Additional Professor of Medical Oncology at the All India Institute of Medical Sciences, New Delhi, India.  He joined the department in 1992 after finishing his initial training in Internal Medicine.  He has the distinction of being the first DM in Medical Oncology from All India Institute of Medical Sciences.  His main areas of interest are clinical research in Head and Neck Cancer and GI Cancers.  He has authored or co-authored more than 100 papers in peer reviewed journals and presented papers in many national and international meetings including ASCO.  He has been involved in about 50 clinical studies (as PI or Co-investigator).  Other than solid cancers his interests include; management of lymphoma and leukemia including stem cell transplantations.

Dr Shilin Shukla, Deputy Director, Research and Surgical Services, Gujarat Cancer & Research Institute (GCRI), Ahmedabad

Dr Shilin Shukla is Director and Professor of Medical Oncologyat the Gujarat Cancer & Research Institute (GCRI), Ahmedabad, India.  He has 20 years experience as a Medical Oncologist and is currently a member of 4 Medical Research Organisational Committees, working to steer medical research for the benefit of patients as opposed to profit.  He is also Author-Editor of the Gujarati Vishwakosh Encyclopaedia (Medical Section) - generating medical literature in Gujarati to help people overcome language barriers in Health.  He has published 132 papers/articles in international, national and state journals as well as 11 articles in books.  He is currently collaborating with INOX on the INDOX Case-control Consortium and hopes to work with INDOX on other projects in the future.

Dr Balasubramanian Sivanesan, Consultant in Medical Oncology, G. Kuppusamy Naidu Memorial Hospital, Coimbatore

Dr Balasubramanian Sivanesan is a Consultant in the Department of Medical Oncology at G. Kuppusamy Naidu Memorial Hospital, Coimbatore.  He specialises in lung, GIT and gynaecological cancers.  His research interests include monoclonal antibodies in colorectal cancers and new molecules in reccurent ovarian cancers. He has experience in phase II and phase III clinical trials over the last 4 years.  The G.Kuppuswamy Naidu Memorial Hospital joined INDOX in 2009 and Dr Sivanesan is Principal Investigator for GIT, lung and gynecological cancers.  They hope to participate in research with the INDOX network in the future.